OTCMKTS:AGTX Agentix (AGTX) Stock Forecast, Price & News $0.07 0.00 (0.00%) (As of 06/2/2023 ET) Add Compare Share Share Today's Range$0.07▼$0.0750-Day Range$0.07▼$0.1052-Week Range$0.06▼$0.25VolumeN/AAverage Volume2,725 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsFinancialsInsider TradesHeadlinesSEC FilingsProfileChartCompetitorsFinancialsInsider TradesHeadlinesSEC Filings About AgentixAgentix Corp.is a biotechnology company, which engages in the development and commercialization of novel therapeutics to treat metabolic diseases, peripheral neuropathy, progressive lung disease and ischemic reperfusion injury. It is focused on the development of synthetic agonists, inverse agonists and antagonists which modulate the endocannabinoid system (ECS). The ECS is a network of G-protein coupled receptors (GPCRs) that help regulate a variety of metabolic and neurotransmission functions. The company was founded on April 18, 2013 and is headquartered in Dana Point, CA.Read More Receive AGTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Agentix and its competitors with MarketBeat's FREE daily newsletter. Email Address AGTX Stock News HeadlinesDecember 20, 2022 | finance.yahoo.comDelveInsight Estimates a Promising Picture of Obesity Pipeline Space Landscape as Key 100+ Pharma Companies Working in the SpaceJanuary 4, 2022 | finanznachrichten.deStock Day Media: AGENTIX Discusses 2022 Clinical Development Efforts and Potential Uplisting with The Stock Day PodcastJune 3, 2023 | Chaikin Analytics (Ad)Wall Street Legend Who Called AMZN Crash Issues New Sell AlertNow, after years of big gains, he says one popular company's day in the sun is finally coming to an end. You must get off this sinking ship – NOW. 1 million people follow him for his surprisingly accurate predictions. His new sell alert could save your wealth in 2023.January 4, 2022 | finance.yahoo.comAGENTIX Discusses 2022 Clinical Development Efforts and Potential Uplisting with The Stock Day PodcastDecember 22, 2021 | finanznachrichten.deAGENTIX Corp.: AGENTIX and RTI International Announce Worldwide Exclusive License and Services AgreementDecember 21, 2021 | finance.yahoo.comAGENTIX and RTI International Announce Worldwide Exclusive License and Services AgreementSeptember 8, 2021 | finanznachrichten.deAGENTIX Corp.: AGENTIX Corporation and the National Health Research Institutions Announce Worldwide Exclusive License AgreementsSeptember 8, 2021 | finance.yahoo.comAGENTIX Corporation and the National Health Research Institutions Announce Worldwide Exclusive License AgreementsJune 3, 2023 | Behind the Markets (Ad)The single greatest medical breakthrough of all time?We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.March 21, 2021 | ca.finance.yahoo.comNurcapital Corporation Ltd. and Green Sky Labs Inc. Announce Signing of Definitive Agreement and Provide Update on Proposed Qualifying TransactionNovember 11, 2020 | finance.yahoo.comAgentix Biopharma CEO, Rudy Mazzocchi, Discusses the Company's Growth Strategy with The Stock Day PodcastOctober 20, 2020 | finance.yahoo.comWhat Kind Of Investors Own Most Of Oil States International, Inc. (NYSE:OIS)?See More Headlines AGTX Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Industry, Sector and Symbol Stock ExchangeOTCMKTS Industry Diversified Industrials Sub-IndustryN/A SectorIndustrials Current SymbolOTCMKTS:AGTX CUSIPN/A CIK1603345 Webfairwindenergyinc.com Phone(321) 299-2014FaxN/AEmployees147,000Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Key ExecutivesSalman HodaChairman. CEO, Secretary & TreasurerMartin SchroederChief Scientific OfficerDavid FieneFinancial ControllerKey CompetitorsAI Technology GroupOTCMKTS:EENXAlfa Laval CorporateOTCMKTS:ALFVFAmeritek VenturesOTCMKTS:ATVKATSOTCMKTS:ATSAFAura SystemsOTCMKTS:AUSIView All Competitors AGTX Stock - Frequently Asked Questions How have AGTX shares performed in 2023? Agentix's stock was trading at $0.1695 at the beginning of 2023. Since then, AGTX stock has decreased by 58.7% and is now trading at $0.07. View the best growth stocks for 2023 here. What is Agentix's stock symbol? Agentix trades on the OTCMKTS under the ticker symbol "AGTX." How do I buy shares of Agentix? Shares of AGTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Agentix's stock price today? One share of AGTX stock can currently be purchased for approximately $0.07. How many employees does Agentix have? The company employs 147,000 workers across the globe. How can I contact Agentix? The official website for the company is fairwindenergyinc.com. The company can be reached via phone at (321) 299-2014. This page (OTCMKTS:AGTX) was last updated on 6/3/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Agentix Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.